CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 102 enrolled
Drug / intervention
standard +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02717273
NCT02717273Phase 3Completed
CompareCT.gov

A Randomized, Prospective Study of Surgical Site Infections in Liver Transplant Patients Receiving Three Days of Peri-operative Antibiotic Prophylaxis Versus Intra-operative Antibiotics Only

University of Virginia·interventional·Posted Mar 23, 2016·Updated Jul 17, 2018

In Brief

A Phase 3 clinical trial evaluating standard, extended, and 1 other intervention for Liver Transplantation and Surgical Site Infection. Completed, enrolled 102 participants.

Detailed Summary

This study will be to prospectively determine differences in Surgical Site Infection (SSI) if a prolonged course of post-operative antibiotics are used following liver transplantation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Transplantation, Surgical Site Infection
Countries--
CollaboratorsNational Institute of Allergy and Infectious Diseases (NIAID)

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 23, 2016
Enrollment StartMar 1, 2009
Primary CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6.6 yearsPosted 10.3 years ago

Interventions

standarddrug

peri-operative antibiotic regimen only

extendeddrug

extended three-day course of antibiotics

liver transplantother

orthotopic liver transplantation